Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
ERJ OPEN RESEARCH(2021)
Abstract
Benralizumab reduces oral corticosteroid requirements in patients with EGPA and leads to improved patient-reported outcome measures https://bit.ly/2GI0vhf.
MoreTranslated text
Key words
eosinophilic granulomatosis,benralizumab,steroid-sparing
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined